Effect of the severity of acute graft-versus-host disease on physical function after allogeneic hematopoietic stem cell transplantation
- 54 Downloads
The purpose of this study was to retrospectively investigate the effect of the severity of acute graft-versus-host disease (GVHD) on physical function after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
76 patients were included as subjects of this study. Severity of acute GVHD was classified according to the method defined by Grucksberg. To evaluate physical function, the knee extensor strength and six-minute walk distance (6MWD) were performed.
Among these patients, 54% developed acute GVHD; of these, 32%, 54%, and 15% of patients had grade I, grade II, and grades III–IV GVHD, respectively. In the grade I–II groups, mild acute GVHD following allo-HSCT resulted in a gradual decline in physical function, which improved at discharge. However, in cases of severe acute GVHD, physical function deteriorated, implementation of rehabilitation became difficult, and the decline in physical function persisted even at discharge.
These results indicate that severe acute GVHD negatively affects physical function leading to longer hospital days because of inadequate rehabilitation interventions.
KeywordsAllogeneic hematopoietic stem cell transplantation (allo-HSCT) Acute graft-versus-host disease (GVHD) Six-minute walk distance (6MWD) Knee extensor strength
We are grateful to the medical, nursing, and laboratory staff of the participating departments for their contributions to this study.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This study was approved by the Institutional Review Board of Kyoto University Hospital conducted in accordance with the international ethical recommendations stated in the Japanese Good Clinical Practice Guidelines.
- 1.The Japanese Data Center for Hematopoietic Cell Transplantation, The Japan Society for Hematopoietic Cell Transplantation (2016) Hematopoietic cell transplantation in Japan annual report of nationwide survey. https://doi.org/10.11386/jst.52.2-3_184
- 2.Lee HJ, Oran B, Saliba RM, Couriel DM, Shin K, Massey P, Neumann J, de Lima M, Champlin R, Giralt S (2006) Steroid myopathy in patients with acute graft-versus-host disease treated with high dose steroid therapy. Bone Marrow Transplant 38(4):299–303. https://doi.org/10.1038/sj.bmt.1705435 CrossRefPubMedGoogle Scholar
- 3.Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AP, Negrin RS, O'Donnell MR, Parker PM et al (1993) Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Engl J Med 329(17):1225–1230. https://doi.org/10.1056/NEJM199310213291703 CrossRefPubMedGoogle Scholar
- 5.Shimizu N, Yoshikawa N, Ito N, Maruyama T, Suzuki Y, Takeda S, Nakae J, Tagata Y, Nishitani S, Takehana K, Sano M, Fukuda K, Suematsu M, Morimoto C, Tanaka H (2011) Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab 13(2):170–182. https://doi.org/10.1016/j.cmet.2011.01.001 CrossRefPubMedGoogle Scholar
- 16.Ishikawa A, Okata Y, Kamisako M, Suzuki T, Miyata C, Tsuji T, Matsumoto H, Kato J, Mori T, Okamoto S, Liu M (2019) Factors affecting lower limb muscle strength and cardiopulmonary fitness after allogeneic hematopoietic stem cell transplantation. Support Care Cancer 27(5):1793–1800. https://doi.org/10.1007/s00520-018-4433-5 CrossRefPubMedGoogle Scholar
- 17.Dignan FL, Clark A, Amrolia P, Cornish J, Jackson G, Mahendra P, Scarisbrick JJ, Taylor PC, Hadzic N, Shaw BE, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation (2012) Diagnosis and management of acute graft-versus-host disease. Br J Haematol 158(1):30–45. https://doi.org/10.1111/j.1365-2141.2012.09129.x CrossRefGoogle Scholar
- 19.Ruutu T, Niederwieser D, Gratwohl A, Apperley JF (1997) A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 19(8):759–764. https://doi.org/10.1038/sj.bmt.1700745 CrossRefPubMedGoogle Scholar
- 21.Martin PJ, Rizzo JD, Wingard JR, Ballen K, Curtin PT, Cutler C, Litzow MR, Nieto Y, Savani BN, Schriber JR, Shaughnessy PJ, Wall DA, Carpenter PA (2012) First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biology of blood and marrow transplantation. Biol Blood Marrow Transplant 18(8):1150–1163. https://doi.org/10.1016/j.bbmt.2012.04.005 CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Baumann FT, Zopf EM, Nykamp E, Kraut L, Schüle K, Elter T, Fauser AA, Bloch W (2011) Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention. Eur J Haematol 87(2):148–156. https://doi.org/10.1111/j.1600-0609.2011.01640.x CrossRefPubMedGoogle Scholar
- 26.Morishita S, Kaida K, Yamauchi S, Wakasugi T, Yoshihara S, Taniguchi K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K (2012) Gender differences in health-related quality of life, physical function and psychological status among patients in the early phase following allogeneic haematopoietic stem cell transplantation. Psychooncology 22(5):1159–1166. https://doi.org/10.1002/pon.3128 CrossRefPubMedGoogle Scholar
- 27.Jarden M, Baadsgaard M, Hovgaard D, Boesen E, Adamsen L (2009) A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant 43(9):725–737. https://doi.org/10.1038/bmt.2009.27 CrossRefPubMedGoogle Scholar
- 32.Morishita S, Kaida K, Yamauchi S, Wakasugi T, Ikegame K, Ogawa H, Domen K (2017) Relationship of physical activity with physical function and health-related quality of life in patients having undergone allogeneic haematopoietic stem-cell transplantation. Eur J Cancer Care (Engl) 26(4). https://doi.org/10.1111/ecc.12669 CrossRefGoogle Scholar
- 33.Takekiyo T, Dozono K, Nara S, Murayama Y, Minamihama N, Nakano N, Kubota A, Tokunaga M, Miyazono T, Takeuchi S, Takatsuka Y, Utsunomiya A (2017) Gender differences in physical function and muscle mass change in patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 52(10):1460–1462. https://doi.org/10.1038/bmt.2017.156 CrossRefPubMedGoogle Scholar